2,4-Dihydroxybenzophenone(BP-1)
CAS:131-56-6 Product spec:≥99.0%
2,4-Dihydroxybenzophenone(BP-1)
CAS NO. : 131-56-6
Specification: Appearance:light yellow crystal
Content≥99.0%
MP: 142-146℃
2,2',4,4'-Tetrahydroxybenzophenone(BP-2)
CAS:131-55-5 Product spec:≥99%
2,2',4,4'-Tetrahydroxybenzophenone(BP-2)
CAS NO. : 131-55-5
Specification: Appearance: light yellow crystal
MP:≥195℃
Content:≥99%
Loss on drying:≤0.5%
4,4'-Dihydroxybenzophenone
CAS:611-99-4 Product spec:≥99.5%
4,4'-Dihydroxybenzophenone
CAS NO. : 611-99-4
Specification: Appearance:white crystal
Assay:≥99.5%
M.P: 211-213°C
4-acetoxyazetidin-2-one
CAS:76855-69-1 Product spec:98.5%
4-acetoxyazetidin-2-one
Molecular Formula:C13H25NO4Si
MW:287.43
CAS:[76855-69-1]
Optical Purity:99% e e
Assay:≥98.5%
[α]D25: +46~+49°(c=0.98 CHCl3)
Mp:104~ 108℃
Containing Water:≤0.2%
Lansoprazole
CAS: Product spec:99%
Lansoprazole is a proton pump inhibitor (PPI) in the same pharmacologic class as omeprazole. Lansoprazole has been marketed for many years and is one of several PPI's available.
Lansoprazole's plas..
Rabeprazole Sodium
CAS: Product spec:99%
Rabeprazole is a prodrug (metabolized by the cytochrome P450 (or CYP450)) - in the acid environment of the parietal cells it turns into active sulphenamide form associated with cysteine of H+, K+ATPas..
Duloxetine HCI
CAS: Product spec:99%
Duloxetine (brand names Cymbalta, Yentreve, and in parts of Europe, Xeristar or Ariclaim) is a drug which is indicated for major depressive disorder (MDD), generalized anxiety disorder (GAD), pain rel..
Itraconazole
CAS: Product spec:99%
The mechanism of action of itraconazole is the same as the other azole antifungals: it inhibits the fungal cytochrome P450 oxidase-mediated synthesis of ergosterol. Because of its ability to inhibit c..
Anastrozole
CAS: Product spec:99%
Anastrozole (INN, trade name: Arimidex) is a drug indicated in the treatment of breast cancer in post-menopausal women. It is used both in adjuvant therapy (i.e. following surgery) and in metastatic b..
Duloxetine Hydrochloride
CAS: Product spec:99%
Duloxetine was created by Lilly researchers. The first publication of the discovery of the novel drug, then known as LY227942, was made in 1988 by David T. Wong and Frank P. Bymaster, two of the resea..